Cargando…

Profile of lebrikizumab and its potential in the treatment of asthma

Interleukin (IL)-13 has been associated with multiple inflammatory features of asthma. It affects multiple cellular lines in asthma and is a key mediator in airway hyperreactivity and remodeling. Periostin, an extracellular protein, has been used as a surrogate marker of IL-13 activity and has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maselli, Diego Jose, Keyt, Holly, Rogers, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539078/ https://www.ncbi.nlm.nih.gov/pubmed/26309415 http://dx.doi.org/10.2147/JAA.S69932

Ejemplares similares

Lebrikizumab in the personalized management of asthma
por: Thomson, Neil C, et al.
Publicado: (2012)

Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis
por: Loh, Tiffany Y, et al.
Publicado: (2020)

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
por: Bernardo, Diana, et al.
Publicado: (2023)

Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)
por: Szefler, Stanley J., et al.
Publicado: (2022)

Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date
por: Labib, Angelina, et al.
Publicado: (2022)

The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge
por: Scheerens, H, et al.
Publicado: (2014)

Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma
por: Nakamura, Yutaka, et al.
Publicado: (2017)

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
por: Hanania, Nicola A, et al.
Publicado: (2015)

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
por: Okragly, Angela J., et al.
Publicado: (2023)

Inhaled Antibiotic Therapy in Chronic Respiratory Diseases
por: Maselli, Diego J., et al.
Publicado: (2017)

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use
por: Maselli, Diego Jose, et al.
Publicado: (2018)

A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
por: Austin, Cary D., et al.
Publicado: (2020)

Reslizumab in the management of poorly controlled asthma: the data so far
por: Maselli, Diego Jose, et al.
Publicado: (2016)

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
por: Stein Gold, Linda, et al.
Publicado: (2023)

Suspecting non‐cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know
por: Maselli, Diego J., et al.
Publicado: (2017)

The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
por: Bashrahil, Bader, et al.
Publicado: (2023)

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
por: Walsh, Garry M
Publicado: (2013)

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere)
por: Simpson, Eric L., et al.
Publicado: (2023)

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study
por: Paller, Amy S., et al.
Publicado: (2023)

Spotlight on fevipiprant and its potential in the treatment of asthma: evidence to date
por: Kao, Christina C, et al.
Publicado: (2019)

Prevention of ventilator-associated pneumonia in the intensive care unit: A review of the clinically relevant recent advancements
por: Keyt, Holly, et al.
Publicado: (2014)

Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
por: Falci, Diego R, et al.
Publicado: (2013)

Dupilumab: a novel treatment for asthma
por: Vatrella, Alessandro, et al.
Publicado: (2014)

Global impact of bronchiectasis and cystic fibrosis
por: Redondo, Margarida, et al.
Publicado: (2016)

Update on Anticytokine Treatment for Asthma
por: Gallelli, Luca, et al.
Publicado: (2013)

Asthma and Its Treatment
Publicado: (1931)

On Asthma, Its Nature and Treatment
Publicado: (1886)

Profile of ciclesonide for the maintenance treatment of asthma
por: Singas, Effie, et al.
Publicado: (2011)

Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma
por: Prosser, Theresa R, et al.
Publicado: (2015)

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial
por: Guttman-Yassky, Emma, et al.
Publicado: (2020)

Profile of pomalidomide and its potential in the treatment of myelofibrosis
por: Gowin, Krisstina L, et al.
Publicado: (2015)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

Profile of evolocumab and its potential in the treatment of hyperlipidemia
por: Cicero, Arrigo FG, et al.
Publicado: (2015)

Profile of minocycline and its potential in the treatment of schizophrenia
por: Zhang, Lulu, et al.
Publicado: (2014)

Profile of selumetinib and its potential in the treatment of melanoma
por: Kim, Dae Won, et al.
Publicado: (2014)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Asthma and Its Radical Treatment
Publicado: (1926)

On Bronchial Asthma: Its Pathology and Treatment
Publicado: (1890)

Profile of veliparib and its potential in the treatment of solid tumors
por: Wagner, Lars M
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r0l1ch0o8b70bpnani2kml00ih